Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Renal/Urologic

[ ¹⁷⁷ Lu]Lu-PSMA-617 vs cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): A randomised, open-label, phase 2 trial

The Lancet | Feb 15, 2021 Renal/Urologic

Population-based prostate cancer screening with magnetic resonance imaging or ultrasonography

JAMA | Feb 15, 2021 Renal/Urologic

Population-level assessment of smoking-related beliefs and behaviors among survivors of genitourinary cancers: An application of the theory of planned behavior

Urology | Feb 12, 2021 Renal/Urologic

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

CA: A Cancer Journal for Clinicians | Feb 08, 2021 Renal/Urologic

Adjuvant pazopanib vs placebo after nephrectomy in patients with localized or locally advanced renal cell carcinoma: Final overall survival analysis of the phase 3 PROTECT Trial trial

European Urology | Jan 20, 2021 Renal/Urologic

Combination of immune checkpoint inhibitors and radiotherapy for advanced non- small-cell lung cancer and prostate cancer: A meta-analysis

Journal of Oncology | Jan 20, 2021 Renal/Urologic

Comparison of systemic treatments for metastatic castration-sensitive prostate cancer

JAMA | Jan 19, 2021 Renal/Urologic

Radical cystectomy against intravesical BCG for high-risk high-grade nonmuscle invasive bladder cancer: Results from the randomized controlled BRAVO-feasibility study

Journal of Clinical Oncology | Dec 23, 2020 Renal/Urologic

Hysterectomy, oophorectomy and risk of renal cell carcinoma

Cancer Epidemiology, Biomarkers & Prevention | Dec 23, 2020 Renal/Urologic

Risk prediction for renal cell carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) prospective cohort study

Cancer Epidemiology, Biomarkers & Prevention | Dec 23, 2020 Renal/Urologic

« Prev 1 … 24 25 26 27 28 … 140 Next »

[ ¹⁷⁷ Lu]Lu-PSMA-617 vs cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): A randomised, open-label, phase 2 trial

Population-based prostate cancer screening with magnetic resonance imaging or ultrasonography

Population-level assessment of smoking-related beliefs and behaviors among survivors of genitourinary cancers: An application of the theory of planned behavior

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Adjuvant pazopanib vs placebo after nephrectomy in patients with localized or locally advanced renal cell carcinoma: Final overall survival analysis of the phase 3 PROTECT Trial trial

Combination of immune checkpoint inhibitors and radiotherapy for advanced non- small-cell lung cancer and prostate cancer: A meta-analysis

Comparison of systemic treatments for metastatic castration-sensitive prostate cancer

Radical cystectomy against intravesical BCG for high-risk high-grade nonmuscle invasive bladder cancer: Results from the randomized controlled BRAVO-feasibility study

Hysterectomy, oophorectomy and risk of renal cell carcinoma

Risk prediction for renal cell carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) prospective cohort study

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

MIP: Traumatic Brain Injury : Dr Nikhilesh Jain

[ 177 Lu]Lu-PSMA-617 vs cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): A randomised, open-label, phase 2 trial

Population-based prostate cancer screening with magnetic resonance imaging or ultrasonography

Population-level assessment of smoking-related beliefs and behaviors among survivors of genitourinary cancers: An application of the theory of planned behavior

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Adjuvant pazopanib vs placebo after nephrectomy in patients with localized or locally advanced renal cell carcinoma: Final overall survival analysis of the phase 3 PROTECT Trial trial

Combination of immune checkpoint inhibitors and radiotherapy for advanced non- small-cell lung cancer and prostate cancer: A meta-analysis

Comparison of systemic treatments for metastatic castration-sensitive prostate cancer

Radical cystectomy against intravesical BCG for high-risk high-grade nonmuscle invasive bladder cancer: Results from the randomized controlled BRAVO-feasibility study

Hysterectomy, oophorectomy and risk of renal cell carcinoma

Risk prediction for renal cell carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) prospective cohort study

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

MIP: Traumatic Brain Injury : Dr Nikhilesh Jain

Select Specialty

Select Topic

[ ¹⁷⁷ Lu]Lu-PSMA-617 vs cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): A randomised, open-label, phase 2 trial